These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 27589058)

  • 1. Interdependence of oxysterols with cholesterol profiles in multiple sclerosis.
    Mukhopadhyay S; Fellows K; Browne RW; Khare P; Krishnan Radhakrishnan S; Hagemeier J; Weinstock-Guttman B; Zivadinov R; Ramanathan M
    Mult Scler; 2017 May; 23(6):792-801. PubMed ID: 27589058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxysterols and apolipoproteins in multiple sclerosis: a 5 year follow-up study.
    Fellows Maxwell K; Bhattacharya S; Bodziak ML; Jakimovski D; Hagemeier J; Browne RW; Weinstock-Guttman B; Zivadinov R; Ramanathan M
    J Lipid Res; 2019 Jul; 60(7):1190-1198. PubMed ID: 31085627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol pathway biomarkers are associated with neuropsychological measures in multiple sclerosis.
    Siddiqui K; Browne RW; Benedict RHB; Jakimovski D; Weinstock-Guttman B; Zivadinov R; Ramanathan M
    Mult Scler Relat Disord; 2023 Jan; 69():104374. PubMed ID: 36403378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol and neurodegeneration: longitudinal changes in serum cholesterol biomarkers are associated with new lesions and gray matter atrophy in multiple sclerosis over 5 years of follow-up.
    Murali N; Browne RW; Fellows Maxwell K; Bodziak ML; Jakimovski D; Hagemeier J; Bergsland N; Weinstock-Guttman B; Zivadinov R; Ramanathan M
    Eur J Neurol; 2020 Jan; 27(1):188-e4. PubMed ID: 31369181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL.
    Jorissen W; Wouters E; Bogie JF; Vanmierlo T; Noben JP; Sviridov D; Hellings N; Somers V; Valcke R; Vanwijmeersch B; Stinissen P; Mulder MT; Remaley AT; Hendriks JJ
    Sci Rep; 2017 Feb; 7():43410. PubMed ID: 28230201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of oxysterols, cholesterol and 25-hydroxy-vitamin D3 in human plasma by LC-UV-MS.
    Narayanaswamy R; Iyer V; Khare P; Bodziak ML; Badgett D; Zivadinov R; Weinstock-Guttman B; Rideout TC; Ramanathan M; Browne RW
    PLoS One; 2015; 10(4):e0123771. PubMed ID: 25875771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma 24-hydroxycholesterol is associated with narrower common carotid artery and greater flow velocities in relapsing multiple sclerosis.
    Jakimovski D; Zivadinov R; Pelizzari L; Dunne-Jaffe C; Browne RW; Bergsland N; Dwyer MG; Weinstock-Guttman B; Ramanathan M
    Mult Scler Relat Disord; 2022 Jul; 63():103906. PubMed ID: 35671670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cholesterol autoxidation products, 7-ketocholesterol and 7β-hydroxycholesterol are associated with serum neurofilaments in multiple sclerosis.
    McComb M; Browne RW; Bhattacharya S; Bodziak ML; Jakimovski D; Weinstock-Guttman B; Kuhle J; Zivadinov R; Ramanathan M
    Mult Scler Relat Disord; 2021 May; 50():102864. PubMed ID: 33677412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine profile, Foxp3 and nuclear factor-kB ligand levels in multiple sclerosis subtypes.
    Alatab S; Maghbooli Z; Hossein-Nezhad A; Khosrofar M; Mokhtari F
    Minerva Med; 2011 Dec; 102(6):461-8. PubMed ID: 22193377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma oxysterol profiling in children reveals 24-hydroxycholesterol as a potential marker for Autism Spectrum Disorders.
    Grayaa S; Zerbinati C; Messedi M; HadjKacem I; Chtourou M; Ben Touhemi D; Naifar M; Ayadi H; Ayedi F; Iuliano L
    Biochimie; 2018 Oct; 153():80-85. PubMed ID: 29730299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-annexin antibodies, cholesterol levels and disability in multiple sclerosis.
    Mandoj C; Renna R; Plantone D; Sperduti I; Cigliana G; Conti L; Koudriavtseva T
    Neurosci Lett; 2015 Oct; 606():156-60. PubMed ID: 26342534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albumin and Protein Oxidation are Predictors that Differentiate Relapsing-Remitting from Progressive Clinical Forms of Multiple Sclerosis.
    Oliveira SR; Kallaur AP; Reiche EMV; Kaimen-Maciel DR; Panis C; Lozovoy MAB; Morimoto HK; Maes M; Dichi I; Simão ANC
    Mol Neurobiol; 2017 May; 54(4):2961-2968. PubMed ID: 27026183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile acid synthesis precursors in subjects with genetic hypercholesterolemia negative for LDLR/APOB/PCSK9/APOE mutations. Association with lipids and carotid atherosclerosis.
    Baila-Rueda L; Cenarro A; Lamiquiz-Moneo I; Mateo-Gallego R; Bea AM; Perez-Calahorra S; Marco-Benedi V; Civeira F
    J Steroid Biochem Mol Biol; 2017 May; 169():226-233. PubMed ID: 27769814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein particle profiles compared with standard lipids in association with coronary artery calcification in the general Japanese population.
    Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Kadota A; Kadowaki S; Kadowaki T; Yamamoto T; Miyagawa N; Zaid M; Torii S; Takashima N; Murakami Y; Okamura T; Horie M; Ueshima H;
    Atherosclerosis; 2014 Oct; 236(2):237-43. PubMed ID: 25105580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidant defense enzymes in multiple sclerosis: A 5-year follow-up study.
    Essenburg C; Browne RW; Ghazal D; Tamaño-Blanco M; Jakimovski D; Weinstock-Guttman B; Zivadinov R; Ramanathan M
    Eur J Neurol; 2023 Aug; 30(8):2338-2347. PubMed ID: 37151181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor (IGF)-I and IGF-binding protein-3 serum levels in relapsing-remitting and secondary progressive multiple sclerosis patients.
    Lanzillo R; Di Somma C; Quarantelli M; Ventrella G; Gasperi M; Prinster A; Vacca G; Pivonello C; Orefice G; Colao A; Morra VB
    Eur J Neurol; 2011 Dec; 18(12):1402-6. PubMed ID: 21585623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
    Thouvenot E; Orsini M; Daures JP; Camu W
    Eur J Neurol; 2015 Mar; 22(3):564-9. PubMed ID: 25530281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyslipoproteinemia in patients with active rheumatoid arthritis: effects of disease activity, sex, and menopausal status on lipid profiles.
    Yoo WH
    J Rheumatol; 2004 Sep; 31(9):1746-53. PubMed ID: 15338494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased MMP-9 production in primary progressive multiple sclerosis patients.
    Sastre-Garriga J; Comabella M; Brieva L; Rovira A; Tintoré M; Montalban X
    Mult Scler; 2004 Aug; 10(4):376-80. PubMed ID: 15327032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases.
    Brettschneider J; Jaskowski TD; Tumani H; Abdul S; Husebye D; Seraj H; Hill HR; Fire E; Spector L; Yarden J; Dotan N; Rose JW
    J Neuroimmunol; 2009 Dec; 217(1-2):95-101. PubMed ID: 19879655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.